Posted on April 16th, 2014 by Center for Individualized Medicine
Article Originally Featured on PR Newswire
Sanguine, a technology company enabling personalized medical research for the development of new and effective treatments, today announced an agreement with Mayo Clinic Bioservices. Under this agreement, Mayo Clinic Bioservices will process, store and ship biospecimens that Sanguine has collected for clients developing new therapies. This will dramatically increase Sanguine's capacity and scalability, allowing the company to serve more clients simultaneously.
Mayo Clinic Bioservices will provide integrated laboratory services that are vital to basic, translational and epidemiological research, including specimen accessioning, processing, nucleic acid extraction, specimen tracking, storage and shipping. Mayo Clinic Bioservices is a new service from the Mayo Clinic Center for Individualized Medicine with locations [...]
Posted on April 10th, 2014 by Center for Individualized Medicine
Article Originally Featured on Mayo Clinic News Network
It has been 1.5 years since Mayo Clinic opened the world’s first integrated multidisciplinary genomics service, the Individualized Medicine Clinic, which uses genomics and next-generation sequencing technologies to personalize treatments for patients with advanced cancer and complex diagnoses. In a special issue of the American Journal of Medical Genetics Part C, “Implementation of Genomic Medicine,” developers of the Individualized Medicine Clinic report the clinic’s structure and share lessons learned in everything from efficacy of genomics in patient [...]
Posted on April 8th, 2014 by Center for Individualized Medicine
Article Originally Featured in Digestive Disease Update
To address the issues of rising cases in children with cases of Clostridium difficile (C. difficile), and the rise of recurrence in children, Mark G. Bartlett, M.D., a pediatric gastroenterologist at Mayo Clinic in Rochester, Minn. initiated a fecal microbiota transplant program for young patients with refractory C. difficile infection in April 2013. Fecal transplants, which aim to restore a normal gut microbiome, have an overall cure rate of more than 90 percent. "At that time, just a few places were doing fecal transplants in children, but we felt we were ready. Mayo Clinic in Arizona has had an [...]
Posted on April 4th, 2014 by AJ Montpetit
There is increasing recognition that genomic medicine as part of individualized medicine has a defined role in patient care. Rapid advances in technology and decreasing cost combine to bring genomic medicine closer to the clinical practice. There is also growing evidence that genomic-based medicine can advance patient outcomes, tailor therapy and decrease side effects.
The promise of genomic medicine, as one part of individualized care, is to enable medical practitioners to make better clinical decisions through an improved informed process.
However the challenges to integrate genomics into the workflow involved in patient care remain vast, stalling assimilation [...]
Posted on April 1st, 2014 by Center for Individualized Medicine
Today's Press Release From ACMG
BETHESDA, Md., APRIL 1, 2014 -- /PRNewswire-USNewswire/ -- There has been significant discussion surrounding the initial ACMG recommendations for the return of results from genome-scale sequencing issued in March of 2013. The ACMG Board of Directors has listened carefully to the members' views and appreciates the many forums in which divergent and valuable opinions have been expressed. The positions of ACMG members regarding the issues raised by the recommendations have been assessed through a variety of mechanisms, including direct feedback, participation by Board members in numerous forums exploring these issues, informal conversations, published articles, commentaries and, most recently, through an extensive member survey, the results of which were presented at the ACMG business meeting at [...]
Posted on March 27th, 2014 by Admin
This year at the ACMG Annual Clinical Genetics Meeting, Richard Sharp, Ph.D., director of the Bioethics Program in the Mayo Clinic Center for Individualized Medicine, will participate on Saturday, March 30, in a panel discussion entitled “Duty to Recontact” in the Genomics Era: Interdisciplinary Perspectives and Open Forum.
“Duty to Recontact” addresses providers’ obligations to patients who have undergone previous genetic testing, given the growing complexities of genetic/genomic medicine and the potential for new findings in old tests. Dr. Sharp is an advisor to the National Institutes of Health, the Institute of Medicine and the Environmental Protection [...]
Posted on March 25th, 2014 by Admin
Mayo Clinic believes the improvement of health care in our nation is tied closely to the ability to successfully create value, deliver knowledge and fund excellence. Our campus in Florida is playing an active role in this vision. In August, we launched theIndividualized Medicine (IM) Clinic. The IM Clinic ushers in a new era in medicine where teams of physicians and scientists leverage exciting new technologies like whole genome sequencing to personalize treatment for patients.
To help Mayo Clinic in Florida take this concept to the next level, Amelia Island, Florida residents and [...]
Posted on March 20th, 2014 by Admin
National DNA Day commemorates the successful completion of the Human Genome Project in 2003 and the discovery of DNA's double helix by James Watson and Francis Crick in 1953. This annual celebration offers students, teachers and the public many exciting opportunities to learn about the latest advances in genomic research and explore what they may mean for their lives.
Individualized health care means better health care, and the Center for Individualized Medicine is leading to increase capabilities for doctors to — for each unique patient — predict and perhaps prevent some diseases, take earlier action when [...]